| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 93.6K | $279.8K | - | |
| Dir | 37.1K | $111.0K | - | |
| Dir | 30.6K | $91.3K | - | |
| Dir | 30.6K | $91.3K | - | |
| Dir | 30.6K | $91.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $25.54 | $63,847.50 | -43.9% | -54.1% | -89.3% | |
| Mar 12, 2021 | Hatzis-Schoch Brent82 | See Remarks | Sale+OE | 4,078 | $26.36 | $107,493.23 | -32.7% | -51.5% | -89.3% | |
| Mar 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $26.10 | $65,261.83 | -25.6% | - | - | |
| Feb 12, 2021 | Hatzis-Schoch Brent82 | See Remarks | Sale+OE | 4,078 | $27.23 | $111,024.94 | -19.2% | - | - | |
| Feb 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $25.35 | $63,375.00 | -43.9% | - | - | |
| Jan 12, 2021 | Hatzis-Schoch Brent82 | See Remarks | Sale+OE | 11,578 | $34.03 | $394,040.62 | -11.3% | - | - | |
| Jan 8, 2021 | Leggett Thomas | Chief Financial Officer | Sale+OE | 3,000 | $33.94 | $101,820.00 | -100% | - | - | |
| Jan 4, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $31.41 | $78,524.67 | -26.5% | - | - | |
| Jan 4, 2021 | Epstein David M. | See Remarks | Sale+OE | 12,000 | $31.13 | $373,504.94 | -0.9% | - | - | |
| Dec 14, 2020 | Hatzis-Schoch Brent82 | See Remarks | Sale+OE | 4,078 | $34.95 | $142,522.43 | -57.6% | - | - |